
High Tide Inc. (NASDAQ: HITI) Stock Competitors & Peer Comparison
See HITI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HITI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HITI | $2.51 | -2.33% | 220.6M | -7.36 | -$0.34 | N/A |
| RPRX | $60.85 | -1.73% | 27B | 11.59 | $5.25 | +1.52% |
| CORT | $113.88 | -2.61% | 12.3B | 325.37 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| KNSA | $78.08 | -0.76% | 6.1B | 88.67 | $0.90 | N/A |
| LQDA | $67.69 | -3.22% | 6B | 483.50 | $0.14 | N/A |
| PBH | $52.47 | +2.46% | 2.5B | 11.87 | $4.42 | N/A |
| LTGO | $24.23 | -3.08% | 1.5B | N/A | N/A | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
HITI vs RPRX Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, RPRX has a market cap of 27B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while RPRX trades at $60.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas RPRX's P/E ratio is 11.59. In terms of profitability, HITI's ROE is -0.43%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, HITI is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for HITI.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
HITI vs CORT Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, CORT has a market cap of 12.3B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while CORT trades at $113.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas CORT's P/E ratio is 325.37. In terms of profitability, HITI's ROE is -0.43%, compared to CORT's ROE of +0.08%. Regarding short-term risk, HITI is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for HITI.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
HITI vs WBA Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas WBA's P/E ratio is -1.64. In terms of profitability, HITI's ROE is -0.43%, compared to WBA's ROE of -0.42%. Regarding short-term risk, HITI is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for HITI.Check WBA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
HITI vs KNSA Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, KNSA has a market cap of 6.1B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while KNSA trades at $78.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas KNSA's P/E ratio is 88.67. In terms of profitability, HITI's ROE is -0.43%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, HITI is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for HITI.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
HITI vs LQDA Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, LQDA has a market cap of 6B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while LQDA trades at $67.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas LQDA's P/E ratio is 483.50. In terms of profitability, HITI's ROE is -0.43%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, HITI is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for HITI.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
HITI vs PBH Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, PBH has a market cap of 2.5B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while PBH trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas PBH's P/E ratio is 11.87. In terms of profitability, HITI's ROE is -0.43%, compared to PBH's ROE of +0.09%. Regarding short-term risk, HITI is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for HITI.Check PBH's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
HITI vs LTGO Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, LTGO has a market cap of 1.5B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while LTGO trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas LTGO's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to LTGO's ROE of N/A. Regarding short-term risk, HITI is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for HITI.Check LTGO's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
HITI vs HROWL Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas HROWL's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, HITI is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for HITI.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
HITI vs HROWM Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas HROWM's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, HITI is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for HITI.Check HROWM's competition here
Cybin Inc. Common Stock (NASDAQ: HELP)
HITI vs HELP Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, HELP has a market cap of 755M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while HELP trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas HELP's P/E ratio is -2.92. In terms of profitability, HITI's ROE is -0.43%, compared to HELP's ROE of -0.71%. Regarding short-term risk, HITI is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for HITI.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
HITI vs SVA Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas SVA's P/E ratio is -5.68. In terms of profitability, HITI's ROE is -0.43%, compared to SVA's ROE of -0.01%. Regarding short-term risk, HITI is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for HITI.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
HITI vs CUVL Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, CUVL has a market cap of 310.6M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while CUVL trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas CUVL's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to CUVL's ROE of N/A. Regarding short-term risk, HITI is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for HITI.Check CUVL's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
HITI vs CELG-RI Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, CELG-RI has a market cap of 244.7M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while CELG-RI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, HITI is less volatile compared to CELG-RI. This indicates lower risk in terms of short-term price fluctuations for HITI.Check CELG-RI's competition here
Atlantic International Corp. (NASDAQ: ATLN)
HITI vs ATLN Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas ATLN's P/E ratio is -0.68. In terms of profitability, HITI's ROE is -0.43%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, HITI is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for HITI.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
HITI vs CTOR Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, CTOR has a market cap of 72.1M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while CTOR trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas CTOR's P/E ratio is -1.65. In terms of profitability, HITI's ROE is -0.43%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, HITI is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for HITI.Check CTOR's competition here
Stablecoin Development Corp. (AMEX: SDEV)
HITI vs SDEV Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, SDEV has a market cap of 47.8M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while SDEV trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas SDEV's P/E ratio is -0.17. In terms of profitability, HITI's ROE is -0.43%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, HITI is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for HITI.Check SDEV's competition here
Rite Aid Corporation (NYSE: RAD)
HITI vs RAD Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas RAD's P/E ratio is -0.05. In terms of profitability, HITI's ROE is -0.43%, compared to RAD's ROE of +2.76%. Regarding short-term risk, HITI is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for HITI.Check RAD's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
HITI vs NSRX Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, NSRX has a market cap of 34.9M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while NSRX trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas NSRX's P/E ratio is -5.62. In terms of profitability, HITI's ROE is -0.43%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, HITI is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for HITI.Check NSRX's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
HITI vs GLTO Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas GLTO's P/E ratio is -1.78. In terms of profitability, HITI's ROE is -0.43%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, HITI is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for HITI.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
HITI vs SCYX Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, SCYX has a market cap of 34M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while SCYX trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas SCYX's P/E ratio is -1.58. In terms of profitability, HITI's ROE is -0.43%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, HITI is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for HITI.Check SCYX's competition here
Cerenome, Inc. (NASDAQ: CNSY)
HITI vs CNSY Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, CNSY has a market cap of 21M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while CNSY trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas CNSY's P/E ratio is -0.42. In terms of profitability, HITI's ROE is -0.43%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, HITI is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for HITI.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
HITI vs BFRI Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, BFRI has a market cap of 20.4M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while BFRI trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas BFRI's P/E ratio is -2.89. In terms of profitability, HITI's ROE is -0.43%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, HITI is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for HITI.Check BFRI's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
HITI vs SCNX Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, SCNX has a market cap of 16M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas SCNX's P/E ratio is -0.16. In terms of profitability, HITI's ROE is -0.43%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, HITI is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for HITI.Check SCNX's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
HITI vs BFRIW Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, BFRIW has a market cap of 14.2M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while BFRIW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas BFRIW's P/E ratio is -0.02. In terms of profitability, HITI's ROE is -0.43%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, HITI is less volatile compared to BFRIW. This indicates lower risk in terms of short-term price fluctuations for HITI.Check BFRIW's competition here
Cosmos Health Inc. (NASDAQ: COSM)
HITI vs COSM Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, COSM has a market cap of 12.2M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while COSM trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas COSM's P/E ratio is -0.30. In terms of profitability, HITI's ROE is -0.43%, compared to COSM's ROE of -1.19%. Regarding short-term risk, HITI is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for HITI.Check COSM's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
HITI vs CJJD Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas CJJD's P/E ratio is -0.46. In terms of profitability, HITI's ROE is -0.43%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, HITI is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for HITI.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
HITI vs SSY Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas SSY's P/E ratio is -2.86. In terms of profitability, HITI's ROE is -0.43%, compared to SSY's ROE of -0.09%. Regarding short-term risk, HITI is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for HITI.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
HITI vs POM Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, POM has a market cap of 6.4M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while POM trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas POM's P/E ratio is -0.19. In terms of profitability, HITI's ROE is -0.43%, compared to POM's ROE of +0.16%. Regarding short-term risk, HITI is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for HITI.Check POM's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
HITI vs BGMS Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, BGMS has a market cap of 4.9M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while BGMS trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas BGMS's P/E ratio is -0.25. In terms of profitability, HITI's ROE is -0.43%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, HITI is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for HITI.Check BGMS's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
HITI vs PAVS Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, PAVS has a market cap of 4.1M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while PAVS trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas PAVS's P/E ratio is -0.05. In terms of profitability, HITI's ROE is -0.43%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, HITI is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for HITI.Check PAVS's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
HITI vs MDVL Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas MDVL's P/E ratio is -0.05. In terms of profitability, HITI's ROE is -0.43%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, HITI is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for HITI.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
HITI vs ATNFW Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas ATNFW's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, HITI is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for HITI.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
HITI vs BGMSP Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, HITI's ROE is -0.43%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, HITI is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for HITI.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
HITI vs AZNH Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas AZNH's P/E ratio is 38.35. In terms of profitability, HITI's ROE is -0.43%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, HITI is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for HITI.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
HITI vs LFLYW Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, HITI's ROE is -0.43%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, HITI is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for HITI.Check LFLYW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
HITI vs PRPH Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, PRPH has a market cap of 295.7K. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while PRPH trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas PRPH's P/E ratio is -0.01. In terms of profitability, HITI's ROE is -0.43%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, HITI is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for HITI.Check PRPH's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
HITI vs CPD Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, CPD has a market cap of 0. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas CPD's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to CPD's ROE of N/A. Regarding short-term risk, HITI is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for HITI.Check CPD's competition here
POZEN Inc. (NASDAQ: POZN)
HITI vs POZN Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, POZN has a market cap of 0. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas POZN's P/E ratio is N/A. In terms of profitability, HITI's ROE is -0.43%, compared to POZN's ROE of +0.61%. Regarding short-term risk, HITI is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for HITI.Check POZN's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
HITI vs ESRX Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas ESRX's P/E ratio is 10.69. In terms of profitability, HITI's ROE is -0.43%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, HITI is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for HITI.Check ESRX's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
HITI vs OREX Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, OREX has a market cap of 0. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas OREX's P/E ratio is -0.14. In terms of profitability, HITI's ROE is -0.43%, compared to OREX's ROE of -0.54%. Regarding short-term risk, HITI is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for HITI.Check OREX's competition here
Shire plc (NASDAQ: SHPG)
HITI vs SHPG Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas SHPG's P/E ratio is 11.35. In terms of profitability, HITI's ROE is -0.43%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, HITI is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for HITI.Check SHPG's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
HITI vs IPXL Comparison September 2026
High Tide Inc. (NASDAQ: HITI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITI stands at 220.6M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, HITI is priced at $2.51 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITI currently has a P/E ratio of -7.36, whereas IPXL's P/E ratio is -10.11. In terms of profitability, HITI's ROE is -0.43%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, HITI is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for HITI.Check IPXL's competition here